ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,956Medicare Part D Prescriptions Filled, Including Refills

Rank: 72 out of 676

$750K Total Retail Price of All Prescriptions

Rank: 110 out of 676

673 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 673 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

22% of this provider’s 673 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 15,191 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
AMLODIPINE BESYLATE 1,015 874 1 3
HYDROCODONE-ACETAMINOPHEN 762 525 S3 2 1
LEVOTHYROXINE SODIUM 584 513 3 7
OMEPRAZOLE 568 470 4 2
LISINOPRIL 563 491 5 5
SIMVASTATIN 515 447 6 6
HYDROCHLOROTHIAZIDE 424 383 7 12
PRAVASTATIN SODIUM 423 375 8 11
METFORMIN HCL 401 343 9 8
METOPROLOL SUCCINATE 371 330 10 14
MELOXICAM 351 326 11 13
FUROSEMIDE 344 290 12 4
GABAPENTIN 312 264 13 10
CITALOPRAM HBR 275 246 14 17
POTASSIUM CHLORIDE 272 231 15 9
TRAMADOL HCL 261 231 16 19
CARVEDILOL 221 200 17 15
ATORVASTATIN CALCIUM 212 189 18 20
GLIMEPIRIDE 204 180 19 30
RANITIDINE HCL 200 171 20 27
WARFARIN SODIUM 190 144 21 18
ZOLPIDEM TARTRATE 187 166 22 21
TAMSULOSIN HCL 179 137 23 38
CIPROFLOXACIN HCL 169 151 24 45
AZITHROMYCIN 166 133 25 39
ALLOPURINOL 155 140 26 31
TRAZODONE HCL 154 137 27 36
TRIAMTERENE-HCTZ 153 148 28 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 152 146 29 16
NEXIUM 148 142 30 23
SERTRALINE HCL 148 129 30 26
ATENOLOL 146 135 32 25
DONEPEZIL HCL 141 138 33 24
PREDNISONE 140 127 34 53
FLUTICASONE PROPIONATE 139 96 35 49
CRESTOR 135 113 36 29
CYMBALTA 134 122 37 47
TIZANIDINE HCL 127 101 38 68
CLOPIDOGREL 125 105 39 28
PANTOPRAZOLE SODIUM 123 90 40 42
PLAVIX 114 103 41 40
LOSARTAN-HYDROCHLOROTHIAZIDE 111 109 42 51
LOSARTAN POTASSIUM 108 107 43 34
SYNTHROID 104 99 44 48
METOPROLOL TARTRATE 103 67 45 22
KLOR-CON M20 103 78 45 67
DIOVAN 97 97 47 37
ALENDRONATE SODIUM 91 81 48 61
NAMENDA 91 91 48 35
BENAZEPRIL HCL 87 72 50 58
LEVOXYL 86 86 51 186
FLUOXETINE HCL 84 70 52 70
METFORMIN HCL ER 82 82 53 63
NAPROXEN SODIUM 76 51 54 194
QUINAPRIL HCL 74 41 55 151
CEFPROZIL 74 61 55 202
DOXYCYCLINE HYCLATE 73 60 57 82
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 63 57 74
AMITRIPTYLINE HCL 72 62 R 59 46
ESTRADIOL 72 68 R 59 109
PROPRANOLOL HCL 72 69 59 120
SYMBICORT 71 65 62 189
AMLODIPINE BESYLATE-BENAZEPRIL 71 56 62 44
PREMARIN 67 54 R 64 128
LOVASTATIN 66 56 65 33
PROAIR HFA 64 45 66 79
RAMIPRIL 63 43 67 86
KLOR-CON 10 63 61 67 95
LANTUS 62 52 69 55
LIPITOR 61 53 70 94
ISOSORBIDE MONONITRATE ER 60 56 71 54
INSULIN SYRINGE 59 41 72 161
NIFEDIPINE ER 59 50 72 100
MIRTAZAPINE 59 59 72 59
LEVOFLOXACIN 58 49 75 91
SPIRIVA 57 42 76 97
PAROXETINE HCL 55 42 77 65
MECLIZINE HCL 54 50 78 83
FENOFIBRATE 54 40 78 90
CLOTRIMAZOLE-BETAMETHASONE 53 50 80 170
CLONIDINE HCL 52 52 81 32
ROPINIROLE HCL 50 26 82 85
DIOVAN HCT 50 42 82 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 6, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.